"With Liberty and Access for All!"
GrandCentral: 517-589-4081
MDRC Website: http://www.copower.org/
LTC Blog: http://ltcreform.blogspot.com/
Recovery: http://therecoveringlife.blogspot.com/
Change: http://prosynergypsc.blogspot.com/
Urinary incontinence sometimes can be resolved with non-drug treatments, he added, so patients should ask about alternatives. Exercises, biofeedback and keeping to a schedule of bathroom breaks work for many.
U.S. sales of prescription drugs to treat urinary problems topped $3 billion in 2007, according to IMS Health, which tracks drug sales. Bladder control trouble affects about one in 10 people age 65 and older, according to the National Institute on Aging, which helped fund the study. Women are more likely to be affected than men. Causes include nerve damage, loss of muscle tone or, in men, enlarged prostate.
Drugmakers increased prices by an average of 7.4 percent last year for the brand-name medicines most commonly prescribed to the elderly, according to the advocacy group <layer id="clearforesthighlight"><layer onmouseout="javascript:gnosisDocMenu(event,false,false);" onmouseover="javascript:gnosisDocMenu(event,true,true);" class="clfAARP" style="border-bottom: 3px double rgb(0, 254, 254);" id="Organization">AARP</layer></layer>.
The increase far exceeded inflation, continuing a longtime trend.
<layer id="clearforesthighlight"><layer onmouseout="javascript:gnosisDocMenu(event,false,false);" onmouseover="javascript:gnosisDocMenu(event,true,true);" class="clfAARP" style="border-bottom: 3px double rgb(0, 254, 254);" id="Organization">AARP</layer></layer> said prices charged to wholesalers have been slightly higher since the <layer id="clearforesthighlight"><layer onmouseout="javascript:gnosisDocMenu(event,false,false);" onmouseover="javascript:gnosisDocMenu(event,true,true);" class="clfMedicare" style="border-bottom: 3px double rgb(0, 254, 254);" id="Organization">Medicare</layer></layer> drug benefit started on Jan. 1, 2006. Since then, the outcry over prices has diminished, with the government picking up much of the tab.
"Unfortunately, many manufacturers have taken the absence of an outcry as a green light to go ahead and raise prices even more," said <layer id="clearforesthighlight"><layer onmouseout="javascript:gnosisDocMenu(event,false,false);" onmouseover="javascript:gnosisDocMenu(event,true,true);" class="clfJohn_Rother" style="border-bottom: 3px double rgb(43, 254, 0);" id="Person">John Rother</layer></layer>, <layer id="clearforesthighlight"><layer onmouseout="javascript:gnosisDocMenu(event,false,false);" onmouseover="javascript:gnosisDocMenu(event,true,true);" class="clfAARP" style="border-bottom: 3px double rgb(0, 254, 254);" id="Organization">AARP</layer></layer>'s policy director.